Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Borrego-Dorado I
- Esteban-Figueruelo A
- Gámez C
- Hladun R
- López-Almaraz R
- Llempén ML
- Rodado S
- Rubio-Aparicio PM
Grupos
Abstract
Neuroblastoma (NB) is the most common extracranial solid cancer in children. Despite intensive multimodality treatment, long-term survival of patients with high-risk NB, which comprises more than half of all cases, remains poor. Nuclear medicine is key in diagnosis, staging, response assessment and long-term follow-up of NB. The emergence of novel tracers and the increasing complexity of studies require updated guidelines for nuclear medicine imaging in NB. Standardising diagnostic techniques are essential for improving study comparability and ensuring test quality. This article aims to provide a comprehensive review of NB radionuclide diagnostic imaging, including its characteristics, accuracy, advantages, and limitations. It offers practical recommendations to multidisciplinary teams responsible for treating patients with NB. This review summarises the opinions of leading experts from the Neuroblastoma Spanish Group within the Spanish Society of Paediatric Haematology and Oncology (SEHOP) and the Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM).
© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Datos de la publicación
- ISSN/ISSNe:
- 1699-048X, 1699-3055
- Tipo:
- Article
- Páginas:
- 2401-2415
- PubMed:
- 39508974
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,764 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
Clinical & Translational Oncology SPRINGER INT PUBL AG
Citas Recibidas en Web of Science: 3
Documentos
- No hay documentos
Filiaciones
Keywords
- 3-Iodobenzylguanidine; Consensus; Diagnosis; Neuroblastoma; Positron-Emission Tomography; Radionuclide imaging
Cita
SÁNCHEZ R,BALAGUER J,Borrego I,Esteban A,Gámez C,Hladun R,López R,Llempén ML,Rodado S,Rubio PM. Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma. Clin. Transl. Oncol. 2025. 27. (6):p. 2401-2415. IF:2,700. (3).
Portal de investigación